Hattersley, A., & Ashcroft, F. (2005). Activating mutations in Kir6.2 and neonatal diabetes: New clinical syndromes, new scientific insights, and new therapy.
Cita Chicago Style (17a ed.)Hattersley, A., y F. Ashcroft. Activating Mutations in Kir6.2 and Neonatal Diabetes: New Clinical Syndromes, New Scientific Insights, and New Therapy. 2005.
Cita MLA (9a ed.)Hattersley, A., y F. Ashcroft. Activating Mutations in Kir6.2 and Neonatal Diabetes: New Clinical Syndromes, New Scientific Insights, and New Therapy. 2005.
Precaución: Estas citas no son 100% exactas.